Newsroom

latest news from ose
and across our portfolio

Featured News

Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
Sitryx
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
The Oxford-Harrington Rare Disease Centre Launches
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
Beacon Therapeutics
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
Oxford University retains No. 1 spot for spinouts
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
Ultromics
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
Caristo Diagnostics
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
Quantum Motion Technologies
Quantum Motion Raises £42 Million Investment Round

All News